论文部分内容阅读
目的探讨联合血清HCG和CA125检测对子宫内膜癌早期诊断的意义。方法选取来院就诊的55~85岁中老年妇女187例,临床上疑诊断子宫内膜癌病变,要求检测妇科肿瘤标志物患者;以及86例20~40岁门诊健康体检者,采取血清进行HCG和CA125检测。结果发现55~85岁的中老年女性HCG和CA125略增高明显高于20~40岁青壮年女性。结论 HCG和CA125联合检测能预防及早期发现子宫内膜癌,重视高危因素,重视高危患者,一定程度地提高子宫内膜癌的确诊率。
Objective To investigate the significance of combined detection of serum HCG and CA125 in the early diagnosis of endometrial cancer. METHODS: A total of 187 middle-aged and elderly women aged 55-85 years old were enrolled in the hospital. The patients with clinically suspected endometrial cancer were enrolled in this study. Patients with gynecologic oncology markers were required for detection of gynecological tumor markers. Eighty-six outpatients with 20-40 age were enrolled in this study. CA125 test. The results showed that 55 to 85-year-old middle-aged women slightly elevated HCG and CA125 was significantly higher than 20 to 40-year-old young women. Conclusion Combined detection of HCG and CA125 can prevent and early detection of endometrial cancer, pay attention to risk factors, and attach importance to high-risk patients, to a certain extent, improve the diagnosis rate of endometrial cancer.